Hanmi Pharm. Co., Ltd.
Symbol: 128940.KS
KSC
322000
KRWDzisiejsza cena rynkowa
24.3478
Wskaźnik P/E
0.0155
Wskaźnik PEG
4.09T
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Hanmi Pharm. Co., Ltd. (128940-KS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 254155.7 | 236736.4 | 211734.4 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 199175.4 | 89407.8 | 2509.7 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 179195.9 | 191163.2 | 241982 | ||||||||||||||
balance-sheet.row.inventory | 0 | 288813.8 | 266185.4 | 250188.7 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 26487.6 | 73.2 | 56.5 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 748652.9 | 694158.3 | 703961.6 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 860242 | 917981.5 | 957218.2 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 47756 | -17742 | 50416.9 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 159972 | 89901.6 | 91855.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 54367 | 155699.5 | 53106.5 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1203382.2 | 1230427.5 | 1232767.1 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 45180.3 | 39709.5 | 42833.4 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 483775.4 | 489193 | 455166.9 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 6741.6 | 22180.1 | 26475 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 82028.4 | 225815.6 | 301099.8 | ||||||||||||||
Deferred Revenue Non Current | 0 | 1033.1 | 8457.6 | 10839.7 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 150970.5 | 131195.3 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 146408.2 | 238610.7 | 359531 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 7063.4 | 48215.1 | 65622.2 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 851824.4 | 915359 | 1008469.3 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 31405.4 | 30794.9 | 30195.7 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 336059.3 | 452297.5 | 396915.9 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 216059.6 | 232729.4 | 200479.4 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 371918.2 | 156043.8 | 175322.8 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 955442.4 | 871865.6 | 802913.7 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 144768.3 | 137361.1 | 125345.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 1100210.6 | 1009226.7 | 928259.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 246931.4 | 71665.7 | 52926.7 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 572867.3 | 715008.6 | 756266.7 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 517886.9 | 567680 | 547042.1 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 146231.2 | 101558.2 | 81478.2 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 98454 | 96842 | 89086.3 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -57396.6 | -73686.3 | -53516.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -2602.8 | 38190.1 | -74313.9 | ||||||||||||||
cash-flows.row.inventory | 0 | -16902.6 | -14365.3 | 18915.7 | ||||||||||||||
cash-flows.row.account-payables | 0 | 5574.2 | -2736.1 | 9794.1 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -43465.5 | -94774.9 | -7912.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 29249.1 | 37555 | 84874.8 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2600.2 | -25772 | -14112.3 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94770.2 | -92923.2 | -7738.6 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 90377.5 | 86.6 | 785.9 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | -133933.2 | -13206.4 | 12101.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -183472.2 | -181408.1 | -43388.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -103371 | -260971.4 | -232371.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 93.5 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3070.6 | -3834.1 | -4873.5 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -17995.6 | -5992.2 | -5881.3 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2443 | 233930.9 | 129795.6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -126786.7 | -36866.8 | -113330.6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1372.9 | -5890 | 17863.5 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -92348.3 | -61896 | 63067.3 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 54980.3 | 147328.7 | 209224.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 147328.7 | 209224.6 | 146157.4 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 216537.6 | 162268.9 | 201923.2 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | 168791.1 | 112675.9 | 167498.3 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1490887.5 | 1331546.6 | 1203185.7 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 655030.7 | 612993.5 | 570433.4 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | 835856.7 | 718553.1 | 632752.2 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 610971.8 | 560462.7 | 507336.4 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1266002.5 | 1173456.3 | 1077769.8 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 4617.7 | 7856.4 | 5722.3 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98454 | 97942.5 | 87056.1 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | 224884.9 | 158090.3 | 125415.9 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | 195267.6 | 121012.5 | 103696.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 28600.6 | 19454.3 | 22218.3 | ||||||||||||||
income-statement-row.row.net-income | 0 | 146231.2 | 82791.7 | 67025.4 |
Często zadawane pytania
Ile wynosi Hanmi Pharm. Co., Ltd. (128940.KS) aktywów ogółem?
Hanmi Pharm. Co., Ltd. (128940.KS) całkowite aktywa to 1952035090968.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.671.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 13515.617.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.108.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.158.
Co to jest Hanmi Pharm. Co., Ltd. (128940.KS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 146231157740.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 572867266550.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 610971802715.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.